First Trust Advisors’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.63M | Buy |
111,056
+31,939
| +40% | +$1.15M | ﹤0.01% | 1738 |
|
|
2026
Q1 | $2.8M | Buy |
79,117
+10,698
| +16% | +$435K | ﹤0.01% | 1768 |
|
|
2025
Q4 | $2.78M | Buy |
68,419
+18,273
| +36% | +$795K | ﹤0.01% | 1731 |
|
|
2025
Q3 | $2.36M | Sell |
50,146
-10,790
| -18% | -$559K | ﹤0.01% | 1761 |
|
|
2025
Q2 | $3.17M | Buy |
60,936
+26,920
| +79% | +$1.48M | ﹤0.01% | 1595 |
|
|
2025
Q1 | $2.05M | Buy |
34,016
+12,761
| +60% | +$823K | ﹤0.01% | 1776 |
|
|
2024
Q4 | $1.45M | Buy |
21,255
+5,309
| +33% | +$370K | ﹤0.01% | 1929 |
|
|
2024
Q3 | $1.15M | Buy |
15,946
+6,705
| +73% | +$473K | ﹤0.01% | 1986 |
|
|
2024
Q2 | $641K | Sell |
9,241
-4,457
| -33% | -$325K | ﹤0.01% | 2070 |
|
|
2024
Q1 | $1.1M | Buy |
13,698
+7,195
| +111% | +$641K | ﹤0.01% | 1958 |
|
|
2023
Q4 | $712K | Buy |
6,503
+419
| +7% | +$43.3K | ﹤0.01% | 2060 |
|
|
2023
Q3 | $614K | Sell |
6,084
-1,021
| -14% | -$117K | ﹤0.01% | 2110 |
|
|
2023
Q2 | $965K | Sell |
7,105
-7,558
| -52% | -$923K | ﹤0.01% | 1996 |
|
|
2023
Q1 | $1.52M | Buy |
14,663
+7,077
| +93% | +$684K | ﹤0.01% | 1815 |
|
|
2022
Q4 | $672K | Buy |
7,586
+444
| +6% | +$36.8K | ﹤0.01% | 2092 |
|
|
2022
Q3 | $573K | Sell |
7,142
-30,283
| -81% | -$2.86M | ﹤0.01% | 2153 |
|
|
2022
Q2 | $3.58M | Buy |
37,425
+15,862
| +74% | +$1.9M | ﹤0.01% | 1437 |
|
|
2022
Q1 | $3.2M | Sell |
21,563
-3,741
| -15% | -$522K | ﹤0.01% | 1574 |
|
|
2021
Q4 | $3.59M | Buy |
25,304
+22,965
| +982% | +$3.25M | ﹤0.01% | 1544 |
|
|
2021
Q3 | $306K | Buy |
2,339
+400
| +21% | +$52.3K | ﹤0.01% | 2382 |
|
|
2021
Q2 | $267K | Buy |
+1,939
| New | +$265K | ﹤0.01% | 2387 |
|
|
2020
Q4 | – | Sell |
-3,331
| Closed | -$262K | – | 2336 |
|
|
2020
Q3 | $262K | Sell |
3,331
-141
| -4% | -$11.5K | ﹤0.01% | 2189 |
|
|
2020
Q2 | $250K | Sell |
3,472
-24,121
| -87% | -$1.68M | ﹤0.01% | 2188 |
|
|
2020
Q1 | $1.58M | Sell |
27,593
-5,216
| -16% | -$481K | ﹤0.01% | 1389 |
|
|
2019
Q4 | $3.67M | Buy |
32,809
+215
| +0.7% | +$22.9K | 0.01% | 1241 |
|
|
2019
Q3 | $3.13M | Sell |
32,594
-7,308
| -18% | -$686K | 0.01% | 1282 |
|
|
2019
Q2 | $3.41M | Sell |
39,902
-787
| -2% | -$64.7K | 0.01% | 1273 |
|
|
2019
Q1 | $3.38M | Buy |
40,689
+3,112
| +8% | +$226K | 0.01% | 1264 |
|
|
2018
Q4 | $2.41M | Sell |
37,577
-23,963
| -39% | -$1.64M | 0.01% | 1369 |
|
|
2018
Q3 | $4.88M | Buy |
61,540
+11,210
| +22% | +$867K | 0.01% | 1155 |
|
|
2018
Q2 | $3.68M | Buy |
50,330
+42,320
| +528% | +$2.88M | 0.01% | 1265 |
|
|
2018
Q1 | $507K | Buy |
+8,010
| New | +$478K | ﹤0.01% | 2020 |
|
|
2017
Q3 | – | Sell |
-7,451
| Closed | -$380K | – | 2403 |
|
|
2017
Q2 | $380K | Sell |
7,451
-11,658
| -61% | -$577K | ﹤0.01% | 2148 |
|
|
2017
Q1 | $849K | Buy |
19,109
+8,582
| +82% | +$369K | ﹤0.01% | 1905 |
|
|
2016
Q4 | $465K | Buy |
10,527
+3,134
| +42% | +$133K | ﹤0.01% | 2152 |
|
|
2016
Q3 | $296K | Sell |
7,393
-6,642
| -47% | -$282K | ﹤0.01% | 2143 |
|
|
2016
Q2 | $670K | Buy |
+14,035
| New | +$594K | ﹤0.01% | 1868 |
|
|
2015
Q4 | – | Sell |
-34,389
| Closed | -$1.64M | – | 2249 |
|
|
2015
Q3 | $1.64M | Buy |
34,389
+6,834
| +25% | +$375K | ﹤0.01% | 1492 |
|
|
2015
Q2 | $1.61M | Buy |
27,555
+14,353
| +109% | +$774K | ﹤0.01% | 1629 |
|
|
2015
Q1 | $667K | Sell |
13,202
-1,175
| -8% | -$57.6K | ﹤0.01% | 1890 |
|
|
2014
Q4 | $646K | Buy |
14,377
+1,792
| +14% | +$75.1K | ﹤0.01% | 1898 |
|
|
2014
Q3 | $464K | Buy |
12,585
+412
| +3% | +$16.3K | ﹤0.01% | 1959 |
|
|
2014
Q2 | $537K | Sell |
12,173
-1,550
| -11% | -$70.3K | ﹤0.01% | 1882 |
|
|
2014
Q1 | $596K | Sell |
13,723
-12,656
| -48% | -$564K | ﹤0.01% | 1863 |
|
|
2013
Q4 | $1.12M | Sell |
26,379
-149
| -0.6% | -$5.66K | 0.01% | 1591 |
|
|
2013
Q3 | $901K | Buy |
26,528
+14,291
| +117% | +$466K | ﹤0.01% | 1601 |
|
|
2013
Q2 | $382K | Buy |
+12,237
| New | +$397K | ﹤0.01% | 1940 |
|
Other funds holding CNMD
ICM
First Trust Advisors's CNMD Position: Q2 2026 in Review
First Trust Advisors increased its CONMED (CNMD) stake by 40% in Q2 2026, buying an estimated $1.15M and bringing the position to 111,056 shares worth $3.63M. The position accounts for ﹤0.01% of the portfolio, ranked #1738.
First Trust Advisors first reported a position in CNMD in Q2 2013 and has held it in 47 quarters since. The position peaked at $4.88M in Q3 2018. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.
- First Trust Advisors held 111,056 shares of CONMED worth $3.63M as of Q2 2026.
- First Trust Advisors bought 31,939 CONMED shares in Q2 2026, an estimated $1.15M.
- CONMED made up ﹤0.01% of First Trust Advisors's portfolio in Q2 2026, its #1738 holding.
- First Trust Advisors first reported a position in CONMED in Q2 2013 and has held it in 47 quarters since.
- First Trust Advisors's CONMED position peaked at $4.88M in Q3 2018.
- 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.
Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.